RenovoRx Inc. (RNXT)
NASDAQ: RNXT
· Real-Time Price · USD
0.95
-0.29 (-23.39%)
At close: Aug 15, 2025, 3:59 PM
0.95
-0.12%
After-hours: Aug 15, 2025, 04:13 PM EDT
RenovoRx Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 240K | 43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 6K | 10K | 15K | 12K | 9K | 5K | n/a | n/a |
Gross Profit | 146K | 43K | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -6K | -10K | -15K | -12K | -9K | -5K | n/a | n/a |
Operating Income | -11.6M | -10.97M | -10.12M | -10.27M | -10.61M | -11.4M | -11.79M | -10.97M | -10.21M | -9.95M | -10.14M | -9.37M | -7.62M | -5.67M | -3.95M | -3.47M | -3.2M |
Interest Income | 347K | 384K | 299K | 218K | 130K | 97K | 111K | 90K | 40K | 36K | 22K | n/a | n/a | n/a | 3K | 3K | 3K |
Pretax Income | -10.16M | -8.81M | -9.16M | -8.11M | -8.05M | -10.23M | -9.16M | -9.88M | -10.14M | -9.89M | -10.09M | -9.46M | -8.18M | -6.32M | -4.85M | -4.43M | -3.9M |
Net Income | -10.16M | -8.81M | -9.16M | -8.11M | -8.05M | -10.23M | -9.09M | -9.75M | -10M | -9.75M | -10.02M | -9.44M | -8.18M | -6.32M | -4.85M | -4.43M | -3.9M |
Selling & General & Admin | 5.34M | 4.99M | 4.89M | 5.07M | 5.03M | 5.73M | 6.12M | 6.08M | 5.86M | 5.65M | 5.51M | 4.82M | 3.93M | 2.63M | 1.56M | 1.12M | 988K |
Research & Development | 6.41M | 6.03M | 5.22M | 5.2M | 5.59M | 5.67M | 5.67M | 4.88M | 4.35M | 4.3M | 4.63M | 4.55M | 3.69M | 3.04M | 2.39M | 2.35M | 2.22M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 4K | 4K | 1K | 1K | -5K | -5K | -5K | -5K |
Operating Expenses | 11.75M | 11.01M | 10.12M | 10.27M | 10.61M | 11.4M | 11.79M | 10.97M | 10.21M | 9.95M | 10.14M | 9.37M | 7.62M | 5.67M | 3.95M | 3.47M | 3.2M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 35K | 35K | 55K | 56K | 250K | 458K | 835K | 834K | 840K | 818K | 592K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.84M | 11.01M | 10.12M | 10.27M | 10.61M | 11.4M | 11.79M | 10.97M | 10.21M | 9.95M | 10.14M | 9.37M | 7.62M | 5.67M | 3.95M | 3.47M | 3.2M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -4K | -75K | -122K | -142K | -140K | -70K | -23K | -3K | -1K | 4K | 4K | 4K |
Shares Outstanding (Basic) | 31.4M | 22.27M | 24.94M | 24.05M | 29.89M | 21.39M | 21.39M | 21.31M | 18.18M | 18.19M | 18.14M | 18.11M | 17.98M | 11.24M | 11.24M | 16.42M | 16.77M |
Shares Outstanding (Diluted) | 31.4M | 22.27M | 24.94M | 24.05M | 29.89M | 21.39M | 21.39M | 21.31M | 18.18M | 18.19M | 18.14M | 18.11M | 17.98M | 11.24M | 11.24M | 16.42M | 16.77M |
EPS (Basic) | -0.41 | -0.36 | -0.38 | -0.35 | -0.36 | -0.51 | -0.47 | -0.52 | -0.55 | -0.54 | -0.64 | -0.65 | -0.59 | -0.49 | -0.33 | -0.27 | -0.23 |
EPS (Diluted) | -0.41 | -0.36 | -0.38 | -0.35 | -0.36 | -0.51 | -0.47 | -0.52 | -0.55 | -0.54 | -0.64 | -0.65 | -0.59 | -0.49 | -0.33 | -0.27 | -0.23 |
EBITDA | -11.6M | -9.57M | -7.44M | -7.6M | -7.94M | -10.12M | -11.79M | -10.97M | -10.2M | -9.94M | -10.13M | -9.36M | -6.75M | -3.75M | -1.4M | -910K | -1.51M |
EBIT | -8.74M | -11.22M | -10.12M | -10.27M | -10.61M | -11.4M | -11.79M | -10.97M | -10.21M | -9.95M | -10.32M | -9.55M | -7.8M | -5.85M | -3.96M | -3.47M | -3.21M |
Depreciation & Amortization | -2.48M | n/a | 2.48M | 2.48M | 2.48M | 6K | -91.5K | -65.92K | -64.42K | -62.92K | 37.08K | 15K | 878K | 1.93M | 2.56M | 3.47M | 3.2M |